📍 BEIJING, CHINA
07.11.2026
US regulator investigates tumour risk in children given Novartis gene therapy
US regulator investigates tumour risk in children given Novartis gene therapy. The US Food and Drug Administration said on Friday it was investigating a risk of neoplasia, or tumour formation including malignancy, ass...